FLIR Systems makes high-tech imaging systems. The stock has been selling off since its last earnings report, despite the fact that earnings and guidance both beat analyst estimates. Perhaps the selloff was because the company failed to issue forward guidance, or perhaps it was because free cash flow took an 18% hit last quarter and FLIR announced a 2.5% debt...
Defense contractor Northop Grumman fell hard toward trend line support both before and after its earnings report last Friday, despite a solid beat of analyst expectations. The fall has occurred as analysts adjusted forward estimates of earnings and sales downward for the next two years. Despite the downward revisions, Northop Grumman remains a growth company, with...
Last week I put up a post titled "HPE sentiment may change for the better," but the post got blocked because I had a link in there that the mods felt constituted advertising. Well, HPE sentiment has begun to change for the better, as I predicted, so I think this is worth an update and repost with the offending link removed. I track metrics of both value and...
Allstate is one of my top picks in terms of both value and sentiment. In terms of technicals, it's a classic potential trend line breakout play. Value After a significant selloff this year, Allstate is still trading near the bottom of its 3-year valuation range in P/E, P/S, and P/D terms. The company is financially healthy, with a 78/100 score for financial...
Abbvie's volume has slackened somewhat after its recent triangle breakout, and it has broken its steep upward trendline. We may see a small correction late this month as Abbvie pulls back toward triangle top. However, if healthcare and pharmaceutical sector earnings continue to deliver this month (as they have so far), then Abbvie should get some buying volume...
On its earnings report today, Microsoft reported better-than-expected earnings and guidance, but issued first-quarter revenue guidance slightly below the Wall Street consensus. The poor revenue guidance was partly, but not completely, offset by slightly better-than expected guidance for first-quarter operating costs. Overall, the magnitude of the earnings beat was...
Bristol-Myers Squibb says it has seen no major business disruptions and expects no decrease in global demand for its drugs this year. That means the 3.5% dividend yield should stay stable, and BMY is a great value at 1.3 PEG. BMY also just got FDA approval for a multiple sclerosis drug, which could turn out to be a pretty big deal. Most of the market has been...
Factset, an agency that polls analysts, released a newsletter today titled "S&P 500 NOW PROJECTED TO REPORT A YOY DECLINE IN EARNINGS IN Q1 2020." The newsletter shows that analyst estimates of S&P 500 earnings have fallen from an expected 7% growth rate in Q1 to an expected -0.1% growth rate, and they're still coming down. However, the newsletter also breaks...
So TradingView is showing the wrong price on this; it's 10.90 right now, having dipped with the rest of the market mid-day after a strong open due to a large earnings and revenue beat. SGC's PEG is 0.8, according to Zacks, and its dividend yield is nearly 4%. That makes it a really good value. Unfortunately SGC offered no guidance, but the earnings and revenue...
I'm uncertain what CURO will do tomorrow after its mixed earnings report, lowish sales guidance, and announcement of a share buyback and first-ever dividend. What I do believe is that the initiation of a dividend will be quite bullish for the stock in the medium-to-long-term. Stocks that initiate a dividend for the first time tend, over the next 6-12 months, to...
Alaska is rated the second-best Airline, according to the Wall Street Journal. It is extremely undervalued, with a PEG ratio of about 0.5. News has been extremely positive for Alaska lately. In terms of technicals, Alaska looks to be right above a volume support and ready to bounce. Another way to play Alaska earnings is to diversify risk by buying the JETS...